Dr. Matthew James Dimagno, MD

Dr. Dimagno practices at Lansing Surgery Center in Lansing, Michigan.

Dr. Dimagno's NPI, 1720160252, was assigned on October 20, 2006. Dr. Dimagno graduated from University of Minnesota Medical School in 1995. Dr. Dimagno holds Michigan license 4301065725.

Dr. Dimagno's primary practice is Lansing Surgery Center, at 1707 Lake Lansing Road, Lansing, MI 48912. The practice phone is (517) 267-0033.

Dr. Dimagno's primary practice is Lansing Surgery Center in Lansing, Michigan. Dr. Dimagno is also affiliated with University of Michigan Health-Sparrow Lansing. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Dimagno to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimagno practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dimagno's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dimagno is licensed in Michigan.

CMS data shows 322 Medicare services from Dr. Dimagno across 10 procedure codes in 2024, for 229 Medicare patients. Medicare paid $30,383 for them.

CMS counts 229 Medicare patients who saw Dr. Dimagno in 2024. The largest group is 65 to 74, with 91 patients. 68% of them have high blood pressure, and 62% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dimagno's median patient age at 58, with 59% women.

In 2024, Dr. Dimagno wrote 609 Medicare Part D claims for 204 patients. 64% of them were for generic drugs. CMS names the drug for 480 of them, across 16 drugs with 11 or more claims each, at $613,305 in total drug cost. In 2023, CMS named 512 claims across 18 drugs.

Dr. Dimagno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dimagno as offering telehealth. CMS counts 53 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Dimagno, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 29 papers to Dr. Dimagno, published from 2003 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Pancreatitis, Pancreas and Cystic Fibrosis Transmembrane Conductance Regulator. Dr. Dimagno has published most often in Pancreas. Dr. Dimagno's most frequent co-authors are Joshua Paul Spaete, Kevin Daniel Platt, MD and Sameer Dev Saini, MD.

CMS Open Payments shows 2 general payments to Dr. Dimagno from 2 drug and device companies from 2020 to 2022. Consulting fees make up the largest share, 100% of the total. Nestle Healthcare Nutrition Inc. paid the most, $2,100.

Dr. Dimagno graduated from University of Minnesota Medical School in 1995.